Healthc Inform Res.  2024 Apr;30(2):127-139. 10.4258/hir.2024.30.2.127.

Effect of Mobile Health Applications on Improving Self-Management Knowledge and Seizure Control in Epilepsy Patients: A Scoping Review

• Ernawati I
• Yasin NM
• Setyopranoto I
• Ikawati Z

• KMID: 2555212
• DOI: http://doi.org/10.4258/hir.2024.30.2.127

Abstract

Objectives
Mobile health app-based interventions are increasingly being developed to support chronic disease management, particularly for epilepsy patients. These interventions focus on managing stress, monitoring drug side effects, providing education, and promoting adherence to medication regimens. Therefore, this scoping review aims to assess how mobile health applications improve epilepsy patients’ knowledge and seizure control, and to identify the features of these apps that are frequently used and have proven to be beneficial.
Methods
This scoping review was conducted using scientific databases such as ScienceDirect, PubMed, and Google Scholar, adhering to the Joanna Briggs Institute guidelines. The review framework consisted of five steps: identifying research questions, finding relevant articles, selecting articles, presenting data, and compiling the results. The literature search included all original articles published in English from 2013 to 2023.
Results
Among six articles that discussed mobile applications for epilepsy patients, all featured similar functionalities, including education on epilepsy management and seizure monitoring. Four of the articles highlighted behavioral interventions, such as reminder systems, designed to improve medication adherence. The remaining two articles focused on a side-effect reporting system that enabled doctors or health workers to evaluate and regularly monitor adverse effects.
Conclusions
This scoping review reveals that mobile health applications employing a combination of educational and behavioral interventions for epilepsy patients significantly improve knowledge about patient self-management and medication adherence. These interventions can prevent seizures, increase awareness, enable better activity planning, improve safety, and reduce the frequency of seizures and side effects of antiepileptic drugs.

Keyword

Epilepsy, Seizures, Mobile Applications, Knowledge, Self-management

Figure

• 

  Figure 1 Flow chart summarizing the literature search strategy and results.

Reference

References

1. Cascino GC, Sirven JI, Tatum WO. Epilepsy. 2nd ed. Hoboken (NJ): John Wiley & Sons;2021.

2. Aminoff M, Douglas V. Nervous system disorders. Papadakis MA, McPhee SJ, Rabow MW, editors. Current medical diagnosis & treatment. 56th ed. New York (NY): Mc-Graw Hill Education;2023. p. 970–1045.

3. World Health Organization. Epilepsy [Internet]. Geneva, Switzerland: World Health Organization;2024. [cited 2024 Apr 20]. Available from: https://www.who.int/news-room/fact-sheets/detail/epilepsy.

4. Nwani PO, Asomugha LA, Arinze EO, Ewereji KO, Nwosu MC, Ogunniyi A. Patterns of antiepileptic drug use and seizure control among people with epilepsy in a suburban community in Southeast Nigeria. Afr J Neurol Sci. 2012; 31(2):36–42.

5. Bonnett LJ, Tudur Smith C, Smith D, Williamson PR, Chadwick D, Marson AG. Time to 12-month remission and treatment failure for generalised and unclassified epilepsy. J Neurol Neurosurg Psychiatry. 2014; 85(6):603–10. https://doi.org/10.1136/jnnp-2013-306040.

6. Faught RE, Weiner JR, Guerin A, Cunnington MC, Duh MS. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia. 2009; 50(3):501–9. https://doi.org/10.1111/j.1528-1167.2008.01794.x.

7. Lie IA, Hoggen I, Samsonsen C, Brodtkorb E. Treatment non-adherence as a trigger for status epilepticus: an observational, retrospective study based on therapeutic drug monitoring. Epilepsy Res. 2015; 113:28–33. https://doi.org/10.1016/j.eplepsyres.2015.03.007.

8. Firmawati E, Setyopanoto I, Pangastuti HS. Mobile health application to support family caregivers in recurrent stroke prevention: scoping review. Open Access Maced J Med Sci. 2021; 9(T5):142–51. https://doi.org/10.3889/oamjms.2021.7859.

9. Volpi SS, Biduski D, Bellei EA, Tefili D, McCleary L, Alves AL, et al. Using a mobile health app to improve patients’ adherence to hypertension treatment: a non-randomized clinical trial. PeerJ. 2021; 9:e11491. https://doi.org/10.7717/peerj.11491.

10. Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015; 13(3):141–6. https://doi.org/10.1097/xeb.0000000000000050.

11. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018; 169(7):467–73. https://doi.org/10.7326/m18-0850.

12. Le Marne FA, Butler S, Beavis E, Gill D, Bye AM. EpApp: development and evaluation of a smartphone/tablet app for adolescents with epilepsy. J Clin Neurosci. 2018; 50:214–20. https://doi.org/10.1016/j.jocn.2018.01.065.

13. Rajbhandari H, Joshi S, Malakar S, Paudel P, Jain P, Uppadaya K, et al. Epilepsy field workers, a smartphone application and telephone telemedicine: safe and effective epilepsy care in rural Nepal. Seizure. 2019; 64:54–8. https://doi.org/10.1016/j.seizure.2018.12.005.

14. Simblett SK, Bruno E, Siddi S, Matcham F, Giuliano L, Lopez JH, et al. Patient perspectives on the acceptability of mHealth technology for remote measurement and management of epilepsy: a qualitative analysis. Epilepsy Behav. 2019; 97:123–9. https://doi.org/10.1016/j.yebeh.2019.05.035.

15. Si Y, Xiao X, Xia C, Guo J, Hao Q, Mo Q, et al. Optimising epilepsy management with a smartphone application: a randomised controlled trial. Med J Aust. 2020; 212(6):258–62. https://doi.org/10.5694/mja2.50520.

16. Mirpuri P, Chandra PP, Samala R, Agarwal M, Doddamani R, Kaur K, et al. The development and efficacy of a mobile phone application to improve medication adherence for persons with epilepsy in limited resource settings: a preliminary study. Epilepsy Behav. 2021; 116:107794. https://doi.org/10.1016/j.yebeh.2021.107794.

17. Choi SA, Lim K, Baek H, Yoo S, Cho A, Kim H, et al. Impact of mobile health application on data collection and self-management of epilepsy. Epilepsy Behav. 2021; 119:107982. https://doi.org/10.1016/j.yebeh.2021.107982.

18. Yoo S, Lim K, Baek H, Jang SK, Hwang GY, Kim H, et al. Developing a mobile epilepsy management application integrated with an electronic health record for effective seizure management. Int J Med Inform. 2020; 134:104051. https://doi.org/10.1016/j.ijmedinf.2019.104051.

19. Mohammadzadeh N, Khenarinezhad S, Ghazanfarisavadkoohi E, Safari MS, Pahlevanynejad S. Evaluation of m-health applications use in epilepsy: a systematic review. Iran J Public Health. 2021; 50(3):459–69. https://doi.org/10.18502/ijph.v50i3.5586.

20. Goldenholz DM, Moss R, Jost DA, Crone NE, Krauss G, Picard R, et al. Common data elements for epilepsy mobile health systems. Epilepsia. 2018; 59(5):1020–6. https://doi.org/10.1111/epi.14066.

21. DiIorio C, Bamps Y, Walker ER, Escoffery C. Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy Behav. 2011; 22(3):469–74. https://doi.org/10.1016/j.yebeh.2011.07.030.

22. Bautista RE. Understanding the self-management skills of persons with epilepsy. Epilepsy Behav. 2017; 69:7–11. https://doi.org/10.1016/j.yebeh.2016.11.022.

23. Joshi R, Tripathi M, Gupta P, Gulati S, Gupta YK. Adverse effects & drug load of antiepileptic drugs in patients with epilepsy: monotherapy versus polytherapy. Indian J Med Res. 2017; 145(3):317–26. https://doi.org/10.4103/ijmr.ijmr_710_15.

24. Obiako OR, Sheikh TL, Kehinde JA, Iwuozo EU, Ekele N, Elonu CC, et al. Factors affecting epilepsy treatment outcomes in Nigeria. Acta Neurol Scand. 2014; 130(6):360–7. https://doi.org/10.1111/ane.12275.

25. Fisher RS, Cross JH, D’Souza C, French JA, Haut SR, Higurashi N, et al. Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia. 2017; 58(4):531–42. https://doi.org/10.1111/epi.13671.

26. Chaka A, Awoke T, Yohannis Z, Ayano G, Tareke M, Abate A, et al. Determinants of depression among people with epilepsy in Central Ethiopia. Ann Gen Psychiatry. 2018; 17:27. https://doi.org/10.1186/s12991-018-0197-z.

27. Blixen C, Ogede D, Briggs F, Aebi ME, Burant C, Wilson B, et al. Correlates of stigma in people with epilepsy. J Clin Neurol. 2020; 16(3):423–32. https://doi.org/10.3988/jcn.2020.16.3.423.

28. Huber R, Weber P. Is there a relationship between socioeconomic factors and prevalence, adherence and outcome in childhood epilepsy? A systematic scoping review. Eur J Paediatr Neurol. 2022; 38:1–6. https://doi.org/10.1016/j.ejpn.2022.01.021.

29. Niriayo YL, Mamo A, Kassa TD, Asgedom SW, Atey TM, Gidey K, et al. Treatment outcome and associated factors among patients with epilepsy. Sci Rep. 2018; 8(1):17354. https://doi.org/10.1038/s41598-018-35906-2.

30. Boon P, Ferrao Santos S, Jansen AC, Lagae L, Legros B, Weckhuysen S. Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update. Acta Neurol Belg. 2021; 121(1):241–57. https://doi.org/10.1007/s13760-020-01488-y.

31. Thompson ME, Goodwin R, Ojeda A, Morris L, Fairman AD. User preferences for the design of a mobile health system to support transition-age youth with epilepsy. J Pediatr Health Care. 2020; 34(3):e28–36. https://doi.org/10.1016/j.pedhc.2019.11.002.

32. Sibernagl S, Lang F. Color of atlas pathophysiology. 3rd ed. New York (NY): Thieme Publishers;2016. p. 364–5.

33. Ikawati Z, Anurogo D. Tata Laksana Terapi Penyakit Sistem Syaraf Pusat [Management of therapy for central nervous system diseases]. Yogyakarta, Indonesia: Bursa Ilmu;2018. p. 89–115.

34. Belayneh Z, Mekuriaw B. A systematic review and meta-analysis of anti-epileptic medication non-adherence among people with epilepsy in Ethiopia. Arch Public Health. 2020; 78:23. https://doi.org/10.1186/s13690-020-00405-2.

35. Ernawati I, Islamiyah WR, Sumarno . How to improve clinical outcome of epileptic seizure control based on medication adherence? A literature review. Open Access Maced J Med Sci. 2018; 6(6):1174–9. https://doi.org/10.3889/oamjms.2018.235.

36. Zena D, Tadesse A, Bekele N, Yaregal S, Sualih N, Worku E. Seizure control and its associated factors among epileptic patients at Neurology Clinic, University of Gondar hospital, Northwest Ethiopia. SAGE Open Med. 2022; 10:20503121221100612. https://doi.org/10.1177/20503121221100612.

37. Ferrari CM, de Sousa RM, Castro LH. Factors associated with treatment non-adherence in patients with epilepsy in Brazil. Seizure. 2013; 22(5):384–9. https://doi.org/10.1016/j.seizure.2013.02.006.

38. Elsayed MA, El-Sayed NM, Badi S, Ahmed MH. Factors affecting adherence to antiepileptic medications among Sudanese individuals with epilepsy: a cross-sectional survey. J Family Med Prim Care. 2019; 8(7):2312–7. https://doi.org/10.4103/jfmpc.jfmpc_405_19.

39. Shegog R, Bamps YA, Patel A, Kakacek J, Escoffery C, Johnson EK, et al. Managing epilepsy well: emerging e-tools for epilepsy self-management. Epilepsy Behav. 2013; 29(1):133–40. https://doi.org/10.1016/j.yebeh.2013.07.002.

40. Pandey DK, Levy J, Serafini A, Habibi M, Song W, Shafer PO, et al. Self-management skills and behaviors, self-efficacy, and quality of life in people with epilepsy from underserved populations. Epilepsy Behav. 2019; 98(Pt A):258–65. https://doi.org/10.1016/j.yebeh.2019.07.042.

41. Escoffery C, McGee R, Bidwell J, Sims C, Thropp EK, Frazier C, et al. A review of mobile apps for epilepsy self-management. Epilepsy Behav. 2018; 81:62–9. https://doi.org/10.1016/j.yebeh.2017.12.010.

42. Tang F, Zhu G, Jiao Z, Ma C, Chen N, Wang B. The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy Behav. 2014; 37:157–64. https://doi.org/10.1016/j.yebeh.2014.05.017.

43. McKellar K, Sillence E. Teenagers, sexual health information and the digital age. McKellar K, Sillence E, editors. Current research on sexual health and teenagers. London, UK: Academic Press;2020. p. 5–23.

44. Michaelis R, Tang V, Nevitt SJ, Wagner JL, Modi AC, LaFrance WC, et al. Cochrane systematic review and meta-analysis of the impact of psychological treatment on health-related quality of life in people with epilepsy: an update by the ILAE Psychology Task Force, highlighting methodological changes. Epileptic Disord. 2021; 23(6):803–11. https://doi.org/10.1684/epd.2021.1357.

45. Falco-Walter JJ, Scheffer IE, Fisher RS. The new definition and classification of seizures and epilepsy. Epilepsy Res. 2018; 139:73–9. https://doi.org/10.1016/j.eplepsyres.2017.11.015.

46. Paschal AM, Hawley SR, St Romain T, Ablah E. Measures of adherence to epilepsy treatment: review of present practices and recommendations for future directions. Epilepsia. 2008; 49(7):1115–22. https://doi.org/10.1111/j.1528-1167.2008.01645.x.

47. Beyene YB, Daba FB, Goro KK, Senbeta BS. Drug therapy problems and predicting factors among ambulatory epileptic patients in Jimma Medical Center, Southwest Ethiopia. PLoS One. 2022; 17(4):e0267673. https://doi.org/10.1371/journal.pone.0267673.

48. French JA, Pedley TA. Clinical practice. Initial management of epilepsy. N Engl J Med. 2008; 359(2):166–76. https://doi.org/10.1056/nejmcp0801738.

49. Ayalew MB, Muche EA. Patient reported adverse events among epileptic patients taking antiepileptic drugs. SAGE Open Med. 2018; 6:2050312118772471. https://doi.org/10.1177/2050312118772471.

50. Perucca P, Carter J, Vahle V, Gilliam FG. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology. 2009; 72(14):1223–9. https://doi.org/10.1212/01.wnl.0000345667.45642.61.

51. Peasah SK, Fishman J, Ems D, Vu M, Huynh TT, Beaty S. Association between adverse events and discontinuation of antiepileptic drugs among drug-naive adults with epilepsy. Drugs Real World Outcomes. 2021; 8(1):5–14. https://doi.org/10.1007/s40801-020-00216-5.

52. Reis TM, Campos M, Nagai MM, Pereira L. Contributions of pharmacists in the treatment of epilepsy: a systematic review. Am J Pharm Benefits. 2016; 8(3):e55–e60.

53. Aliasgharpour M, Dehgahn Nayeri N, Yadegary MA, Haghani H. Effects of an educational program on self-management in patients with epilepsy. Seizure. 2013; 22(1):48–52. https://doi.org/10.1016/j.seizure.2012.10.005.

54. Wagner JL, Modi AC, Johnson EK, Shegog R, Escoffery C, Bamps Y, et al. Self-management interventions in pediatric epilepsy: what is the level of evidence? Epilepsia. 2017; 58(5):743–54. https://doi.org/10.1111/epi.13711.

55. Ozuna J, Kelly P, Towne A, Hixson J. Self-management in epilepsy care: untapped opportunities. Fed Pract. 2018; 35(Suppl 3):S10–6.

56. Singh S, Mishra VN, Rai A, Singh R, Chaurasia RN. Myths and superstition about epilepsy: a study from North India. J Neurosci Rural Pract. 2018; 9(3):359–62. https://doi.org/10.4103/jnrp.jnrp_63_18.

57. Aljedaani B, Babar MA. Challenges with developing secure mobile health applications: systematic review. JMIR Mhealth Uhealth. 2021; 9(6):e15654. https://doi.org/10.2196/15654.

58. Zubaydi F, Saleh A, Aloul F, Sagahyroon A. Security of mobile health (mHealth) systems. In : Proceedings of 2015 IEEE 15th International Conference on Bioinformatics and Bioengineering (BIBE); 2015 Nov 2–4; Belgrade, Serbia. p. 1–5. https://doi.org/10.1109/BIBE.2015.7367689.

59. Lewis TL, Wyatt JC. mHealth and mobile medical Apps: a framework to assess risk and promote safer use. J Med Internet Res. 2014; 16(9):e210. https://doi.org/10.2196/jmir.3133.

60. Moalong KM, Espiritu AI, Fernandez ML, Jamora RD. Treatment gaps and challenges in epilepsy care in the Philippines. Epilepsy Behav. 2021; 115:107491. https://doi.org/10.1016/j.yebeh.2020.107491.

61. Abreu M, Carmo AS, Franco A, Parreira S, Vidal B, Costa M, et al. Mobile applications for epilepsy: where are we? where should we go? A systematic review. Signals. 2022; 3(1):40–65. https://doi.org/10.3390/signals3010005.

62. Patel J, Feng W, Chen K, French JA, Rushton M, Hubbard S, et al. Use of an electronic seizure diary in a randomized, controlled trial of natalizumab in adult participants with drug-resistant focal epilepsy. Epilepsy Behav. 2021; 118:107925. https://doi.org/10.1016/j.yebeh.2021.107925.